Search
for
Sort by
Research 601–630 of 1000+
- Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations
- Perfectionism and Baldness Distress in Men
- Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
- Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Male pattern baldness and the risk of prostate cancer
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Androgenetic alopecia as an early marker of benign prostatic hyperplasia
- Dutasteride for the treatment of benign prostatic hyperplasia
- Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- Cardiovascular effects of hormone therapy for prostate cancer
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?